HNF1A and obesity due to melanocortin 4 receptor deficiency: Improvements in obesity-related metabolic abnormalities with the DASH diet have been demonstrated in adolescent populations, and may have synergistic therapeutic effects with specific diabetes subtypes associated with obesity, such as HNF1A-MODY (68).